CVS Nov 2024 85.000 call
| Previous close | 0.2000 |
| Open | 0.1200 |
| Bid | 0.2400 |
| Ask | 0.2900 |
| Strike | 85.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.1200 - 0.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 186 |
Investor's Business DailyDrug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.
BloombergWalgreens’ Shares Plunge on Outlook Cut, More Store Closings
(Bloomberg) -- Walgreens Boots Alliance Inc. slashed its guidance due to a worsening retail environment and announced it would close significantly more stores as its new chief executive officer seeks to turn the business around.Most Read from BloombergSupreme Court Poised to Allow Emergency Abortions in IdahoSpaceX Tender Offer Said to Value Company at Record $210 BillionSupreme Court Ends OxyContin Settlement, Cracking Sackler ShieldChina’s Finance Elite Face $400,000 Pay Cap, Bonus ClawbacksBo
ZacksIs It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
